Evidence map›Paper›PMID 42438643›Full record

ArticleCureus2026

Benchmark Comparison of Bone Marrow Aspiration Systems: Increased Progenitor Cell Concentrations Achieved Without Centrifugation Using a Novel Filtration Design With High Surface Area.

Anthony Scillia, Teo Mendez, Dan Kuebler, Bob Salvat

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anthony ScilliaSports Medicine/Orthopedics, Seton Hall University, Paterson, USA.
Teo MendezSports Medicine, Lenox Hill Hospital, New York, USA.
Dan KueblerDepartment of Biology, Franciscan University of Steubenville, Steubenville, USA.
Bob SalvatDepartment of Clinical Research, SurGenTec, LLC, Boca Raton, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Bone marrow aspirate (BMA) is widely used in orthopedic and regenerative procedures due to its content of mesenchymal stromal cells (MSCs), hematopoietic progenitors, and supportive cellular elements that contribute to bone healing and tissue repair. Conventional bone marrow aspiration techniques are limited by progressive hemodilution, in which peripheral blood increasingly contaminates the aspirate as volume is drawn from a fixed location. This process both reduces MSC and progenitor concentrations and increases variability in aspirate samples. Objectives The purpose of this study was to characterize the cell yield of a novel bone marrow aspiration system (B-MAN™ Bone Marrow Aspiration System, SurGenTec, Boca Raton, FL) under standardized testing conditions. These results were compared with published benchmark data from a study that analyzed centrifuge-processed bone marrow concentrate (BMAC) systems and a no-spin aspiration device analyzed in the same reference laboratory used in this study. Methods A retrospective analysis was performed on bone marrow aspirate obtained from the anterior iliac crest of five adult male subjects (age range 18-44) using the B-MAN™ system during elective orthopedic procedures. Procedures included anterior cruciate ligament reconstruction, hip labral repair, anterior cruciate ligament

Indexed as

bmacbone marrow aspiratebone marrow concentratecentrifugationcolony-forming unit-fibroblasthemodilutionmesenchymal stem cellsorthobiologicsprogenitor cellsregenerative medicine

Identifiers

PMID42438643
PMCPMC13356904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.